Literature DB >> 24236830

Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia.

Perri R Tutelman1, Geraldine Aubert, Ruth A Milner, Bakul I Dalal, Kirk R Schultz, Rebecca J Deyell.   

Abstract

The significance of paroxysmal nocturnal haemoglobinuria (PNH(pos) ) cells and leucocyte subset telomere lengths in paediatric aplastic anaemia (AA) is unknown. Among 22 children receiving immunosuppressive therapy (IST) for AA, 73% (16/22) were PNH(pos) , of whom 94% achieved at least a partial response (PR) to IST; 11/16 (69%) achieved complete response (CR). Only 2/6 (33%) PNH(neg) patients achieved PR. PNH(pos) patients were less likely to fail IST compared to PNH(neg) patients (odds ratio 0·033; 95% confidence interval 0·002-0·468; P = 0·012). Children with AA had short granulocyte (P = 7·8 × 10(-9) ), natural killer cell (P = 6·0 × 10(-4) ), naïve T lymphocyte (P = 0·002) and B lymphocyte (P = 0·005) telomeres compared to age-matched normative data.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  aplastic anaemia; children; immunosuppressive therapy; leucocyte telomeres; paroxysmal nocturnal haemoglobinuria phenotype cells

Mesh:

Substances:

Year:  2013        PMID: 24236830     DOI: 10.1111/bjh.12656

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

1.  Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Authors:  Atsushi Narita; Hideki Muramatsu; Yuko Sekiya; Yusuke Okuno; Hirotoshi Sakaguchi; Nobuhiro Nishio; Nao Yoshida; Xinan Wang; Yinyan Xu; Nozomu Kawashima; Sayoko Doisaki; Asahito Hama; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Masao Kobayashi; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

Review 2.  Diagnosis and Treatment of Aplastic Anemia.

Authors:  Scott A Peslak; Timothy Olson; Daria V Babushok
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

3.  Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated?

Authors:  S Nakao; R P Gale
Journal:  Leukemia       Date:  2016-09-02       Impact factor: 11.528

4.  Long-term outcomes of 172 children with severe aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine.

Authors:  Yang Lan; Lixian Chang; Meihui Yi; Yuli Cai; Jing Feng; Yuanyuan Ren; Chao Liu; Xiaoyan Chen; Shuchun Wang; Ye Guo; Aoli Zhang; Lipeng Liu; Jingliao Zhang; Xiaofan Zhu
Journal:  Ann Hematol       Date:  2020-10-08       Impact factor: 3.673

Review 5.  Recent advances in understanding clonal haematopoiesis in aplastic anaemia.

Authors:  Natasha Stanley; Timothy S Olson; Daria V Babushok
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

6.  The GPI-anchored protein CD109 protects hematopoietic progenitor cells from undergoing erythroid differentiation induced by TGF-β.

Authors:  Mikoto Tanabe; Kohei Hosokawa; Mai Anh Thi Nguyen; Noriharu Nakagawa; Kana Maruyama; Noriaki Tsuji; Ryota Urushihara; Luis Espinoza; Mahmoud I Elbadry; Md Mohiuddin; Takamasa Katagiri; Masanori Ono; Hiroshi Fujiwara; Kazuhisa Chonabayashi; Yoshinori Yoshida; Hirohito Yamazaki; Atsushi Hirao; Shinji Nakao
Journal:  Leukemia       Date:  2021-11-06       Impact factor: 11.528

Review 7.  Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.

Authors:  Atsushi Narita; Seiji Kojima
Journal:  Int J Hematol       Date:  2016-04-18       Impact factor: 2.490

8.  Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.

Authors:  Wenrui Yang; Xin Zhao; Guangxin Peng; Li Zhang; Liping Jing; Kang Zhou; Yang Li; Lei Ye; Yuan Li; Jianping Li; Huihui Fan; Yang Yang; Fengkui Zhang
Journal:  Ann Hematol       Date:  2021-07-16       Impact factor: 3.673

Review 9.  Updated Guidelines for the Treatment of Acquired Aplastic Anemia in Children.

Authors:  Nao Yoshida; Seiji Kojima
Journal:  Curr Oncol Rep       Date:  2018-06-30       Impact factor: 5.075

10.  The clinical significance of PNH-phenotype cells accounting for < 0.01% of total granulocytes detected by the Clinical and Laboratory Standards Institute methods in patients with bone marrow failure.

Authors:  Kohei Hosokawa; Ken Ishiyama; Toshiyuki Ikemoto; Chiharu Sugimori; Hideyoshi Noji; Tsutomu Shichishima; Naoshi Obara; Shigeru Chiba; Haruhiko Ninomiya; Mai Anh Thi Nguyen; Yukari Shirasugi; Yoshihiko Nakamura; Kiyoshi Ando; Yasutaka Ueda; Yuji Yonemura; Tatsuya Kawaguchi; Jun-Ichi Nishimura; Yuzuru Kanakura; Shinji Nakao
Journal:  Ann Hematol       Date:  2020-10-23       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.